Search

everythinglearnresearchcommunity

for

Search:↓

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Electric pulses can effectively activate platelets and release growth factors, offering a better alternative to traditional methods.

Photobiomodulation effectively improves skin and hair conditions with minimal side effects.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

TPA is about 50 times more effective at promoting tumors than MZ.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Apoptosis contributes to hair loss in androgenetic alopecia.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Iron deficiency is linked to female pattern hair loss.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

The study aims to create a model to improve personalized and preventive health care.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Minoxidil helps grow longer, thicker hair in bald scalps of stumptailed macaques, and early treatment is more effective.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Gene mutations can cause problems in male genital development.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.